To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCDC88BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
139 supporting clones for gene CCDC88B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC151218 Donated clones,Novartis FGA collection .a 1 to 4828 1 to 4830 D492R P493T V494L L495F P496F ... tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 4830/4830
(100 %)
2 diff
(100.0 %id)
BC151222 Donated clones,Novartis FGA collection .a 1 to 4828 1 to 4830 D492R P493T V494L L495F P496F ... AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 4830/4830
(100 %)
2 diff
(100.0 %id)
NM_032251.5   .b 1 to 4919 1 to 4919 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 4919/4919
(100 %)
0 diff
(100 %id)
BC140822 Brain, cerebral cortex, PCR rescued clones .b 12 to 4894 1 to 4883 W639R D886A tiling clone,   4883/4883
(100 %)
3 diff
(100.0 %id)
BC140824 Brain, cerebral cortex, PCR rescued clones .b 12 to 4894 1 to 4883 W639R D886A     4883/4883
(100 %)
2 diff
(100.0 %id)
TI_1959499897   .b 12 to 1110 84 to 1175       1092/1198
(91 %)
30 diff
(97.5 %id)
TI_1959499901   .b 12 to 1115 86 to 1184       1099/1252
(87 %)
11 diff
(99.2 %id)
BC141866 PCR rescued clones .b 22 to 3771 1 to 3750       3750/3750
(100 %)
2 diff
(100.0 %id)
CR986992 T-Lymphocytes .b 142 to 922 1 to 781       781/781
(100 %)
1 diff
(99.9 %id)
CT004601 T-Lymphocytes .b 148 to 875 1 to 734       734/749
(97 %)
10 diff
(98.7 %id)
CN345505 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 258 to 732 10 to 487       478/487
(98 %)
11 diff
(97.8 %id)
TI_1971556015   .b 400 to 1302 922 to 19       904/930
(97 %)
19 diff
(98.0 %id)
TI_1959502305   .b 462 to 1506 16 to 1054       1039/1248
(83 %)
13 diff
(99.0 %id)
TI_1959502319   .b 462 to 1503 14 to 1048       1035/1235
(83 %)
13 diff
(99.0 %id)
TI_1959502301   .b 1016 to 2062 1 to 1044       1044/1246
(83 %)
14 diff
(98.9 %id)
BU195410 eye, retinoblastoma .b 1351 to 1899 1 to 550       550/1036
(53 %)
17 diff
(98.4 %id)
TI_1959502311   .b 1555 to 2571 4 to 1018       1015/1250
(81 %)
6 diff
(99.6 %id)
TI_1959502313   .b 1558 to 2657 7 to 1099       1093/1276
(85 %)
22 diff
(98.3 %id)
CR623413 B cells (Ramos cell line) Cot 25-normalized .b 1682 to 4872 1 to 3191   tiling clone,   3191/3191
(100 %)
0 diff
(100 %id)
BX384834   .b 1682 to 2627 1 to 945       945/945
(100 %)
1 diff
(99.9 %id)
BI025247 marrow .b 1891 to 2265 380 to 6       375/380
(98 %)
0 diff
(100 %id)
BI000671 head_normal .b 1944 to 2246 1 to 297       297/315
(94 %)
12 diff
(96.2 %id)
CN345504 embryonic stem cells, cell lines H1, H7, andH9 .b 1999 to 2606 1 to 609       609/609
(100 %)
7 diff
(98.9 %id)
BU854817 ovary, teratocarcinoma, cell line .b 2009 to 2708 1 to 704       704/934
(75 %)
11 diff
(98.9 %id)
BX328251   .b 2451 to 3355 1 to 908       908/908
(100 %)
22 diff
(97.6 %id)
BF901780 marrow .b 2618 to 3011 401 to 10     Submitted on the opposite strand 394/401
(98 %)
1 diff
(99.8 %id)
TI_1959502267   .b 2703 to 3856 1145 to 15       1135/1258
(90 %)
26 diff
(98.0 %id)
BE241518 leukopheresis .b 2755 to 2909 1 to 155       155/155
(100 %)
1 diff
(99.4 %id)
BM194552 leukopheresis .b 2755 to 3335 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BM150422 leukopheresis .b 2755 to 3226 1 to 473       473/473
(100 %)
1 diff
(99.8 %id)
BM151480 leukopheresis .b 2755 to 3077 1 to 323       323/323
(100 %)
8 diff
(97.6 %id)
BI025062 marrow .b 2842 to 3169 1 to 336       336/347
(96 %)
19 diff
(94.6 %id)
TI_1959502317   .b 2849 to 3856 1021 to 15       1007/1243
(81 %)
3 diff
(99.8 %id)
CR987611 T-Lymphocytes .b 2909 to 3648 1 to 740       740/742
(99 %)
3 diff
(99.6 %id)
BM046183 carcinoma, cell line, Prostate .b 2936 to 3650 1 to 721       721/851
(84 %)
12 diff
(98.6 %id)
BQ944786 carcinoma, cell line, Prostate .b 2938 to 3736 1 to 802       802/931
(86 %)
13 diff
(98.7 %id)
BU542529 carcinoma, cell line, Prostate .b 2938 to 3666 1 to 736       736/1025
(71 %)
22 diff
(97.9 %id)
BU542550 carcinoma, cell line, Prostate .b 2938 to 3550 1 to 615       615/861
(71 %)
13 diff
(98.5 %id)
CR988297 T-Lymphocytes .b 3011 to 3699 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
CR999475 T-Lymphocytes .b 3031 to 3615 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
CR994834 T-Lymphocytes .b 3083 to 3729 1 to 647       647/647
(100 %)
0 diff
(100 %id)
BI836637 pooled pancreas and spleen .b 3104 to 3880 1 to 777       777/777
(100 %)
5 diff
(99.4 %id)
TI_57167469   .b 3104 to 3880 57 to 833       777/833
(93 %)
5 diff
(99.4 %id)
CN345503 embryonic stem cells, cell lines H1, H7, andH9 .b 3163 to 3834 13 to 686       674/686
(98 %)
2 diff
(99.8 %id)
BQ706508 Spleen .b 3175 to 4039 1 to 871       869/878
(98 %)
18 diff
(98.0 %id)
BQ052264 blood, natural killer cells, cell line .b 3216 to 4045 1 to 834       834/1049
(79 %)
10 diff
(99.1 %id)
BQ053526 blood, natural killer cells, cell line .b 3216 to 4041 1 to 837       837/841
(99 %)
18 diff
(97.9 %id)
CR988045 T-Lymphocytes .b 3242 to 4028 1 to 786       786/850
(92 %)
1 diff
(99.9 %id)
BX372241   .b 3268 to 4149 881 to 1       881/881
(100 %)
10 diff
(98.9 %id)
BQ056644 lymph, lymphoma, cell line .b 3284 to 4040 1 to 760       760/1021
(74 %)
9 diff
(99.2 %id)
BF846846 lung_normal .b 3572 to 3978 434 to 27     Submitted on the opposite strand 406/446
(91 %)
1 diff
(99.8 %id)
CD672940 eye, Iris .b 3630 to 4048 1 to 419       419/419
(100 %)
0 diff
(100 %id)
BQ064009 lymph, lymphoma, cell line .b 3632 to 4040 1 to 410       410/410
(100 %)
2 diff
(99.6 %id)
BQ065975 lymph, lymphoma, cell line .b 3632 to 4052 1 to 421       421/1422
(29 %)
3 diff
(99.8 %id)
BG993122 head_neck .b 3834 to 4017 184 to 2       189/188
(100 %)
6 diff
(96.9 %id)
BX384833   .b 3897 to 4855 972 to 16       957/972
(98 %)
22 diff
(97.8 %id)
BI911893 leukocyte .b 3954 to 4723 28 to 799       772/800
(96 %)
7 diff
(99.2 %id)
TI_57232610   .b 3954 to 4723 28 to 799       772/800
(96 %)
7 diff
(99.2 %id)
TI_1959499905   .b 4019 to 4899 991 to 110       882/1260
(70 %)
29 diff
(97.7 %id)
TI_1959499909   .b 4043 to 4899 963 to 108       856/963
(88 %)
11 diff
(98.9 %id)
CR982697 T-Lymphocytes .b 4112 to 4902 1 to 792       792/792
(100 %)
1 diff
(99.9 %id)
BM150271 leukopheresis .b 4134 to 4756 623 to 1       623/628
(99 %)
8 diff
(98.8 %id)
CA307125 Alveolar Macrophage, lung .b 4203 to 4910 726 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 708/708
(100 %)
1 diff
(99.9 %id)
CA428241 Bone, Subchondral Bone .b 4213 to 4910 716 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 698/698
(100 %)
1 diff
(99.9 %id)
BG332064 large cell carcinoma, lung .b 4258 to 4920 1 to 664       664/679
(97 %)
7 diff
(99.0 %id)
DR421943 eye, Pterygium .b 4272 to 4908 674 to 38   AAA Submitted on the opposite strand 637/639
(99 %)
0 diff
(100 %id)
BE279930 choriocarcinoma, placenta .b 4303 to 4908 1 to 608       608/608
(100 %)
2 diff
(99.7 %id)
BE280962 choriocarcinoma, placenta .b 4304 to 4906 1 to 601       601/602
(99 %)
3 diff
(99.6 %id)
BE244215 leukopheresis .b 4374 to 4756 383 to 1       383/383
(100 %)
8 diff
(98.0 %id)
TI_57190941   .b 4405 to 4875 50 to 527       478/768
(62 %)
14 diff
(98.2 %id)
BI857851 breast, mammary adenocarcinoma, cell line .b 4406 to 4875 1 to 477       477/767
(62 %)
14 diff
(98.2 %id)
BM149775 leukopheresis .b 4417 to 4756 338 to 1       338/356
(94 %)
16 diff
(95.6 %id)
BQ027800 mixed .b 4428 to 4910 502 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 484/492
(98 %)
1 diff
(99.8 %id)
BM152030 leukopheresis .b 4454 to 4756 303 to 1       303/307
(98 %)
2 diff
(99.4 %id)
AW474559 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4457 to 4920 469 to 6   tiling clone,   464/469
(98 %)
0 diff
(100 %id)
BE674671 B-cell, chronic lymphotic leukemia .b 4459 to 4911 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AI005468 pooled .b 4462 to 4911 450 to 2       449/452
(99 %)
0 diff
(100 %id)
BM193525 leukopheresis .b 4464 to 4756 293 to 1       293/293
(100 %)
2 diff
(99.4 %id)
AI684384 B-cell, chronic lymphotic leukemia .b 4511 to 4913 405 to 3       403/405
(99 %)
0 diff
(100 %id)
BE222756 brain, oligodendroglioma .b 4517 to 4919 416 to 14   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 403/403
(100 %)
1 diff
(99.8 %id)
DB509453 testis .b 4522 to 4910 1 to 391     Submitted on the opposite strand 391/391
(100 %)
8 diff
(98.0 %id)
F32169 pectoral muscle (after mastectomy) .b 4533 to 4805 1 to 273       273/273
(100 %)
3 diff
(99.0 %id)
TI_182940176   .b 4540 to 4910 463 to 93   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 371/418
(88 %)
3 diff
(99.3 %id)
CN480750 Aveolar Macrophage, lung .b 4540 to 4910 389 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 371/383
(96 %)
3 diff
(99.3 %id)
AW440939 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .b 4548 to 4913 371 to 6       366/371
(98 %)
0 diff
(100 %id)
AI475864 B-cell, chronic lymphotic leukemia .b 4549 to 4917 399 to 31   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 369/369
(100 %)
15 diff
(96.0 %id)
AA861443   .b 4577 to 4916 343 to 6       338/343
(98 %)
0 diff
(100 %id)
AA428174 ovarian tumor, ovary .b 4585 to 4920 1 to 332   fully sequenced,   332/332
(100 %)
6 diff
(98.2 %id)
AA430629 ovarian tumor, ovary .b 4683 to 4920 238 to 1   fully sequenced,   238/238
(100 %)
3 diff
(98.8 %id)
AA515594 colon .b 4715 to 4920 206 to 2       205/206
(99 %)
0 diff
(100 %id)
CD633742   .b 4759 to 4912 156 to 3       154/163
(94 %)
0 diff
(100 %id)
CD633743   .b 4759 to 4912 8 to 162       155/163
(95 %)
4 diff
(97.6 %id)
CR984329 T-Lymphocytes .b 4763 to 4920 1 to 158       158/172
(91 %)
1 diff
(99.5 %id)
D20647   .b 4860 to 4911 1 to 52     Submitted on the opposite strand 52/54
(96 %)
1 diff
(98.2 %id)
AK090436 Spleen .c 1 to 5235 1 to 5234 L291W D886A C1035* tiling clone, available from FLJ,   5234/5234
(100 %)
8 diff
(99.9 %id)
BM153454 leukopheresis .c 2750 to 3090 1 to 340       340/351
(96 %)
7 diff
(98.1 %id)
DR006855 Spleen .c 3014 to 3649 1 to 636   tiling clone,   636/636
(100 %)
4 diff
(99.4 %id)
AK074126 Spleen .d 1 to 4563 1 to 4564 Q289P E290R S291V G292R S293L ... tiling clone, available from FLJ,   4564/4564
(100 %)
2 diff
(100.0 %id)
DB636297 testis .e 1 to 660 1 to 660   tiling clone,   660/660
(100 %)
1 diff
(99.9 %id)
BC040232 Brain, adult medulla .e 12 to 2336 1 to 2325 D38A tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 2325/2325
(100 %)
1 diff
(100.0 %id)
BI828018 brain, medulla .e 12 to 549 1 to 543   available from MGC,   541/543
(99 %)
23 diff
(95.8 %id)
TI_57171666   .e 12 to 549 31 to 573       541/573
(94 %)
4 diff
(99.4 %id)
BM563720 brain, medulla .e 14 to 939 5 to 946       942/1054
(89 %)
44 diff
(95.9 %id)
AK095289 tongue, tumor tissue .f 1 to 2908 2 to 2909 D535A tiling clone, available from FLJ,   2909/2909
(100 %)
3 diff
(99.9 %id)
DA441121 tongue, tumor tissue .f 1 to 513 2 to 514   capped   513/513
(100 %)
1 diff
(99.9 %id)
BF902560 marrow .f 1771 to 2035 48 to 313       266/313
(84 %)
0 diff
(100 %id)
CN278942 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 1934 to 2240 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
CN278943 embryonic stem cells, cell lines H1, H7, andH9 .f 1955 to 2570 1 to 618   tiling clone,   618/618
(100 %)
2 diff
(99.7 %id)
BQ710159 Spleen .g 1 to 506 1 to 508   tiling clone,   508/1164
(43 %)
18 diff
(98.5 %id)
BF352978 head_neck .g 63 to 455 393 to 1       393/393
(100 %)
2 diff
(99.5 %id)
TI_44459675   .g 203 to 813 105 to 713       609/713
(85 %)
0 diff
(100 %id)
BI518766 leukocyte .g 204 to 813 1 to 608   tiling clone,   608/608
(100 %)
2 diff
(99.7 %id)
CR985419 T-Lymphocytes .g 278 to 702 1 to 426       426/432
(98 %)
2 diff
(99.6 %id)
BI519715 leukocyte .g 1559 to 2373 864 to 6       859/976
(88 %)
29 diff
(97.1 %id)
TI_44459676   .g 1559 to 2373 864 to 6   tiling clone,   859/976
(88 %)
29 diff
(97.1 %id)
CT000780 T-Lymphocytes .h 1 to 480 1 to 480   tiling clone,   480/482
(99 %)
2 diff
(99.6 %id)
BI023858 marrow .h 48 to 250 16 to 216       201/226
(88 %)
4 diff
(98.3 %id)
AK126728 cerebellum .h 136 to 3237 1 to 3100   tiling clone, available from FLJ,   3100/3100
(100 %)
46 diff
(98.6 %id)
DA115414 cerebellum .h 137 to 685 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
TI_159683154   .i 1 to 789 918 to 132 L2R G3A N4Q S6P A12P ... tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 787/993
(79 %)
16 diff
(98.4 %id)
BQ424009 melanotic melanoma, skin .i 9 to 787 1 to 781   tiling clone,   781/910
(85 %)
9 diff
(99.1 %id)
CR998053 T-Lymphocytes .j 1 to 618 1 to 618 E197X Q199X C200X A205X tiling clone,   618/620
(99 %)
1 diff
(99.9 %id)
DA080244 cerebellum .k 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
DA457087 tongue, tumor tissue .k 20 to 596 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DB119621 thymus .k 20 to 549 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA443611 tongue, tumor tissue .k 33 to 580 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
CR987529 T-Lymphocytes .l 1 to 714 1 to 715 E5X A6C A7C G8W Q9P ... tiling clone,   715/735
(97 %)
11 diff
(98.6 %id)
DN995440 breast cancer, Mammary gland (cancer tissue) .m 1 to 397 8 to 404   tiling clone,   397/404
(98 %)
0 diff
(100 %id)
BX280238 pooled lung and spleen .m 129 to 638 1 to 510 exact     510/510
(100 %)
0 diff
(100 %id)
BC030194 Lung, Spleen, fetal, pooled .m 129 to 1074 1 to 946 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 946/946
(100 %)
0 diff
(100 %id)
BI769480 pooled lung and spleen .m 129 to 911 1 to 782 exact available from MGC,   782/782
(100 %)
7 diff
(99.2 %id)
TI_57182500   .m 129 to 911 30 to 811 exact     782/811
(96 %)
6 diff
(99.3 %id)
AL136799 testis .m 195 to 1074 1 to 879 exact available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 879/879
(100 %)
1 diff
(99.9 %id)
DA923617 small intestine .n 1 to 546 2 to 550 R133P P134A F135P P136S tiling clone, capped   549/553
(99 %)
5 diff
(99.1 %id)
AY491401   Gene CCDC88B, variant not shown         Suspected internal deletion, this clone was ignored    
H26806 breast Gene CCDC88B, variant not shown         This clone was ignored    
AA757416 pineal gland Gene CCDC88B, variant not shown         Suspected internal deletion, this clone was ignored    
BI911326 leukocyte Gene CCDC88B, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57231546   Gene CCDC88B, variant not shown         Suspected internal deletion, this clone was ignored    
DA645339   Gene CCDC88B, variant not shown       capped Suspected internal deletion, this clone was ignored    
CT002359 T-Lymphocytes Gene CCDC88B, variant not shown         Suspected internal deletion, this clone was ignored    
CT004193 T-Lymphocytes Gene CCDC88B, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI